google-site-verification: googlec7193c3de77668c9.html

Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy

[
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B-cell-depleting therapy, is as effective as ocrelizumab in newly diagnosed relapsing multiple sclerosis (MS). The study, known as OVERLORD-MS, is the first randomized, double-blind, head-to-head trial comparing the two therapies in early MS. Patients from across Norway and Sweden were followed for 30 months with MRI and clinical assessments.


Source link

Advertisements
Views: 1

See also  Insulin and metformin combo aids diabetic foot ulcer healing, new study finds

Check Also

How to deal with excessive sweating

Summer can be tough if you struggle with sweating or chafing. Dr Ranj explains when …

BCG vaccine may rewire brain immunity, shift Alzheimer's markers over 12 months

[ New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) …

CDC urges people to prevent mosquito bites as West Nile virus season hits a strong, early start

[ A municipal biologist examines a mosquito in Salt Lake City, Aug. 26, 2019. Credit: …

Leave a Reply

Available for Amazon Prime